Efficacy of a culturally tailored mobile health lifestyle intervention on cardiovascular health among African Americans with preexisting risk factors: The FAITH! Trial.

Mathias Lalika, Sarah Jenkins, Sharonne N Hayes, Clarence Jones, Lora E Burke, Lisa A Cooper, Christi A Patten, LaPrincess C Brewer
Author Information
  1. Mathias Lalika: Department of Cardiovascular Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
  2. Sarah Jenkins: Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  3. Sharonne N Hayes: Department of Cardiovascular Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA. ORCID
  4. Clarence Jones: Department of Cardiovascular Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
  5. Lora E Burke: School of Nursing and Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
  6. Lisa A Cooper: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  7. Christi A Patten: Department of Psychiatry and Psychology, Mayo Clinic College of Medicine, Rochester, MN, USA.
  8. LaPrincess C Brewer: Department of Cardiovascular Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA. ORCID

Abstract

Background: African Americans have a higher prevalence of cardiovascular risk factors, leading to higher cardiovascular disease mortality than White adults. Our culturally tailored mobile health (mHealth) lifestyle intervention () has previously demonstrated efficacy in promoting ideal cardiovascular health in African Americans.
Methods: We conducted a secondary analysis from a cluster randomized controlled trial among African-Americans from 16 churches in Minnesota that compared the to a delayed intervention control group. A subgroup of participants with ≥ 1 diagnosis of overweight/obesity, hyperlipidemia, hypertension, or diabetes was examined. The primary outcome was a change in LS7 score-a measure of cardiovascular health ranging from poor to ideal (range 0-14 points)-at 6-months post-intervention.
Results: The analysis included 49 participants (intervention group:  = 20; mean age 58.8 years, 75% female; control group:  = 29, mean age 52.5 years, 76% female) with no significant baseline differences in cardiovascular risk factors. Compared to the control group, the intervention group showed a greater increase in LS7 score across all cardiovascular risk factors at 6-months post-intervention, with statistically significant differences among those with overweight/obesity (intervention effect 1.77,  < 0.0001) and 2+ or 3+ cardiovascular risk factors (1.00,  = 0.03; 1.09,  = 0.04). The intervention group demonstrated a higher increase in the percentage of participants with intermediate or ideal LS7 scores than the control group, although these differences were not statistically significant.
Conclusions: Our culturally tailored mHealth lifestyle intervention was associated with significant increases in LS7 scores among African Americans with preexisting cardiovascular risk factors, suggesting its efficacy in improving cardiovascular health among this population.

Keywords

References

  1. Mhealth. 2021 Apr 20;7:32 [PMID: 33898601]
  2. Am Heart J. 2022 May;247:1-14 [PMID: 35065922]
  3. JMIR Mhealth Uhealth. 2015 Nov 04;3(4):e101 [PMID: 26537656]
  4. Circulation. 2022 Sep 13;146(11):822-835 [PMID: 35766033]
  5. JAMA Netw Open. 2023 Dec 1;6(12):e2345964 [PMID: 38039001]
  6. BMJ Open. 2020 Jan 7;10(1):e031799 [PMID: 31915161]
  7. Am J Public Health. 2019 Mar;109(3):385-386 [PMID: 30726121]
  8. JAMA. 2021 Oct 5;326(13):1286-1298 [PMID: 34609450]
  9. Health Promot Pract. 2024 Jan;25(1):8-12 [PMID: 36189723]
  10. Curr Atheroscler Rep. 2023 Aug;25(8):467-477 [PMID: 37428390]
  11. Circ Cardiovasc Qual Outcomes. 2024 Feb;17(2):e010009 [PMID: 38377225]
  12. West J Nurs Res. 2020 Jan;43(1):73-84 [PMID: 32400300]
  13. Circulation. 2022 Dec 20;146(25):e558-e568 [PMID: 36373541]
  14. Circulation. 2022 Aug 2;146(5):e18-e43 [PMID: 35766027]
  15. Nurs Open. 2021 Sep;8(5):2078-2090 [PMID: 34388862]
  16. Ethn Dis. 2011 Spring;21(2):129-34 [PMID: 21749014]
  17. NPJ Digit Med. 2023 Aug 18;6(1):150 [PMID: 37596488]
  18. Circ Cardiovasc Qual Outcomes. 2022 Nov;15(11):e009328 [PMID: 36378765]
  19. PEC Innov. 2023 May 26;2:100171 [PMID: 37384154]
  20. J Am Heart Assoc. 2020 Oct 20;9(19):e016482 [PMID: 32928039]
  21. Circulation. 2022 Jul 19;146(3):175-190 [PMID: 35861762]
  22. Circulation. 2015 Sep 22;132(12):1157-213 [PMID: 26271892]
  23. Circulation. 2010 Feb 2;121(4):586-613 [PMID: 20089546]
  24. J Clin Endocrinol Metab. 2019 Nov 1;104(11):5084-5090 [PMID: 30994885]
  25. Circulation. 2023 Jan 17;147(3):190-200 [PMID: 36334260]
  26. Sci Rep. 2022 Nov 14;12(1):19475 [PMID: 36376533]
  27. Digit Health. 2019 Oct 10;5:2055207619882181 [PMID: 31656632]
  28. Nat Med. 2022 Aug;28(8):1679-1692 [PMID: 35915156]
  29. Atherosclerosis. 2018 Aug;275:174-181 [PMID: 29920438]
  30. Nutrients. 2018 Nov 02;10(11): [PMID: 30400139]
  31. Digit Health. 2022 Jul 18;8:20552076221110537 [PMID: 35874864]
  32. Circulation. 2024 Feb 20;149(8):e347-e913 [PMID: 38264914]
  33. BMC Public Health. 2020 May 19;20(1):726 [PMID: 32429951]
  34. Circ Heart Fail. 2017 Feb;10(2): [PMID: 28209767]
  35. JMIR Form Res. 2020 Nov 17;4(11):e21450 [PMID: 33200999]
  36. Circulation. 2022 Mar 15;145(11):808-818 [PMID: 35094551]
  37. Rev Relig Res. 2014 Dec;56(4):513-538 [PMID: 25580034]
  38. Circulation. 2023 Nov 14;148(20):1606-1635 [PMID: 37807924]
  39. JAMA. 2015 Jul 7;314(1):52-60 [PMID: 26151266]
  40. Circ Res. 2022 Mar 4;130(5):782-799 [PMID: 35239404]
  41. Circulation. 2016 Aug 9;134(6):472-85 [PMID: 27324491]
  42. JMIR Mhealth Uhealth. 2021 Apr 22;9(4):e27383 [PMID: 33885368]
  43. Mayo Clin Proc. 2023 Dec;98(12):1875-1887 [PMID: 38044003]
  44. JMIR Mhealth Uhealth. 2020 Jan 14;8(1):e14512 [PMID: 31934874]
  45. J Am Heart Assoc. 2020 Mar 3;9(5):e013220 [PMID: 32070204]

Word Cloud

Created with Highcharts 10.0.0cardiovascularhealthinterventionriskfactorsAfricanAmericansamonggroupcontrol1LS7significanthigherculturallytailoredmobilelifestyleidealparticipantsdifferencesmHealthdemonstratedefficacyanalysisoverweight/obesity6-monthspost-interventiongroup:meanageyearsfemaleincreasestatistically = 0scorespreexistingBackground:prevalenceleadingdiseasemortalityWhiteadultspreviouslypromotingMethods:conductedsecondaryclusterrandomizedcontrolledtrialAfrican-Americans16churchesMinnesotacompareddelayedsubgroupdiagnosishyperlipidemiahypertensiondiabetesexaminedprimaryoutcomechangescore-ameasurerangingpoorrange0-14points-atResults:included49 = 2058875% = 2952576%baselineComparedshowedgreaterscoreacrosseffect77< 000012+3+00030904percentageintermediatealthoughConclusions:associatedincreasessuggestingimprovingpopulationEfficacyfactors:FAITH!TrialCardiovasculardigital

Similar Articles

Cited By